PhRMA Drug Pricing Comments Mainly Stick To Script

With only one new proposal, brand industry association seems to banking on strength of past policy positions as Trump's drug pricing blueprint moves towards implementation stage.

PS1801_Prescription Pad_593365520_1200.jpg

More from Pricing Debate

More from Market Access